ulcerative colitis, inflammatory bowel disease, IBD, UC Researchers performed a systematic review of clinical trials to assess the need for a consensus on the definition of mild to moderate, active ...

The two main types of IBD are ulcerative colitis (UC) and Crohn's disease (CD). Do you or someone you love have moderate to ...

Ischemic colitis reduces blood flow to the colon or large intestine. Mesenteric ischemia is a reduction in blood flow to the small intestine due to the narrowing of the arteries. Both conditions are ...

Immune-mediated diarrhea and colitis (IMDC) is among the most common immune-related adverse events in patients with cancer treated with immune checkpoint inhibitors (ICIs). Many factors will affect ...

For the 907,000 Americans with ulcerative colitis, living with symptoms like urgent bowel movements, abdominal cramps, and loose or bloody stools can be overwhelming, but treatments can help keep ...

The initial manifestations of ulcerative colitis, although unpleasant and discomforting, are not necessarily alarming. Stomach cramps, diarrhoea and even rectal bleeding can arise from various ...

Fulminant colitis is a somewhat rare but serious form of ulcerative colitis (UC). UC causes inflammation and sores in the lining of the colon. It doesn’t happen to most people who have UC. Less than ...

Fulminant colitis is a rare but severe form of colitis that can be life threatening. It affects the entire lining of the colon, causing severe inflammation and potentially serious complications. In ...

Ulcerative colitis is a type of inflammatory bowel disease (IBD) that causes inflammation of the colon, and leads to symptoms such as fatigue, abdominal pain, and cramping. There is currently no cure ...

May 24 (Reuters) - Nearly one third of patients with ulcerative colitis who received an experimental Pfizer Inc (PFE.N), opens new tab drug in a clinical trial were in remission after a year of ...

Immune-mediated diarrhea and colitis (IMDC) is among the most common immune-related adverse events in patients with cancer treated with immune checkpoint inhibitors (ICIs). Many factors will affect ...